Program
ropanicant
Also written as “Ropanicant” and “SUVN-911”.
Its studies are mostly in Depressive Disorder, Major, led by Suven Life Sciences.
Furthest: phase 2, since Nov 6, 20234 company-led studies, 0 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Suven Life Sciences | 40 open or running | phase 2since Nov 6, 2023 | May 11, 2017 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- May 11, 2017First study: phase 1 study in Depressive Disorder, MajorFirst studyNCT03155503 · 64 enrolled · United States
- May 28, 2018Phase 1 study in Depressive Disorder, MajorNCT03551288 · 28 enrolled · United States
- Nov 6, 2023Phase 2 study in Depressive Disorder, MajorNCT06126497 · 41 enrolled · United States
- Feb 18, 2025Phase 2 study in Depressive Disorder, MajorNCT06836063 · 214 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06836063Depressive Disorder, Major · United States | 2 | Completed | Feb 23, 2026 | 214 |
| NCT06126497Depressive Disorder, Major · United States | 2 | Completed | Jul 19, 2024 | 41 |
| NCT03551288Depressive Disorder, Major · United States | 1 | Completed | Jul 10, 2018 | 28 |
| NCT03155503Depressive Disorder, Major · United States | 1 | Completed | Mar 7, 2018 | 64 |
How it is read
Names in the registry
- “Ropanicant”, 2 entries
- “SUVN-911”, 2 entries
Codes read as this program: SUVN911.
Conditions, from the studies’ own filings
- Depressive Disorder, Major, 4 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.